CORVUS PHARMACEUTICALS INC's ticker is CRVS and the CUSIP is 221015100. A total of 53 filers reported holding CORVUS PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $88,000 | +10.0% | 21,909 | -0.0% | 0.00% | – |
| Q4 2018 | $80,000 | -79.4% | 21,913 | -51.6% | 0.00% | – |
| Q3 2018 | $388,000 | +26.4% | 45,290 | +62.2% | 0.00% | – |
| Q2 2018 | $307,000 | +14.6% | 27,924 | +20.0% | 0.00% | – |
| Q1 2018 | $268,000 | +11.2% | 23,275 | 0.0% | 0.00% | – |
| Q4 2017 | $241,000 | -36.9% | 23,275 | -2.8% | 0.00% | – |
| Q3 2017 | $382,000 | +35.0% | 23,948 | +2.5% | 0.00% | – |
| Q2 2017 | $283,000 | +89.9% | 23,354 | +225.2% | 0.00% | – |
| Q1 2017 | $149,000 | +106.9% | 7,181 | +43.3% | 0.00% | – |
| Q4 2016 | $72,000 | -4.0% | 5,011 | +9.3% | 0.00% | – |
| Q3 2016 | $75,000 | -69.8% | 4,583 | -73.6% | 0.00% | – |
| Q2 2016 | $248,000 | – | 17,361 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ADAMS STREET PARTNERS LLC | 3,275,616 | $7,501,161 | 1.96% |
| TOWERVIEW LLC | 205,000 | $469,450 | 0.31% |
| Orbimed Advisors | 6,943,654 | $15,900,968 | 0.29% |
| CHI Advisors LLC | 200,000 | $458,000 | 0.14% |
| BVF INC/IL | 1,370,947 | $3,139,469 | 0.09% |
| SAMLYN CAPITAL, LLC | 2,105,930 | $4,822,580 | 0.08% |
| MYDA Advisors LLC | 100,000 | $229,000 | 0.07% |
| DIFESA CAPITAL MANAGEMENT, LP | 10,000 | $22,900 | 0.06% |
| JACKSON SQUARE CAPITAL, LLC | 63,773 | $146,040 | 0.06% |
| CORNERCAP INVESTMENT COUNSEL INC | 97,248 | $222,698 | 0.04% |